Drug
14c VX 407
14c VX 407: highest development phase Phase 1, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| 14C-VX-407 NCT07868926 | Phase 1 | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
Latest
No recent events.
Follow 14c VX 407 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.